Current Vaccine Recomendations

Generic Lab Tubes and Plates

AIVC recommendation for the composition of influenza vaccine for Australia in 2021

9 October 2020

The AIVC met on 7 October 2020 and recommended that the following viruses be used for influenza vaccines in the 2021 Southern Hemisphere influenza season:

Egg based vaccines:

  • an A/Victoria/2570/2019 (H1N1)pdm09-like virus
  • an A/Hong Kong/2671/2019 (H3N2)-like virus;
  • a B/Washington/02/2019-like (B/Victoria lineage) virus; and
  • a B/Phuket/3073/2013-like (B/Yamagata lineage) virus.

    • Cell or recombinant based vaccines:

  • an A/Wisconsin/588/2019 (H1N1)pdm09-like virus;
  • an A/Hong Kong/45/2019 (H3N2)-like virus;
  • a B/Washington/02/2019-like (B/Victoria lineage) virus; and
  • a B/Phuket/3073/2013-like (B/Yamagata lineage) virus.

    • See the TGA website for further information

    Top of Page

    2021 WHO Southern Hemisphere recommendations

    25 September 2020

    It is recommended that quadrivalent vaccines for use in the 2021 influenza season (Southern Hemisphere winter) contain the following:

    Egg based vaccines:

  • an A/Victoria/2570/2019 (H1N1)pdm09-like virus
  • an A/Hong Kong/2671/2019 (H3N2)-like virus;
  • a B/Washington/02/2019-like (B/Victoria lineage) virus; and
  • a B/Phuket/3073/2013-like (B/Yamagata lineage) virus.

    • Cell or recombinant based vaccines:

  • an A/Wisconsin/588/2019 (H1N1)pdm09-like virus;
  • an A/Hong Kong/45/2019 (H3N2)-like virus;
  • a B/Washington/02/2019-like (B/Victoria lineage) virus; and
  • a B/Phuket/3073/2013-like (B/Yamagata lineage) virus.

    • It is recommended that trivalent vaccines for use in the 2021 influenza season (Southern Hemisphere winter) contain the following:

    Egg based vaccines:

  • an A/Victoria/2570/2019 (H1N1)pdm09-like virus
  • an A/Hong Kong/2671/2019 (H3N2)-like virus; and
  • a B/Washington/02/2019-like (B/Victoria lineage) virus

    • Cell or recombinant based vaccines:

  • an A/Wisconsin/588/2019 (H1N1)pdm09-like virus;
  • an A/Hong Kong/45/2019 (H3N2)-like virus; and
  • a B/Washington/02/2019-like (B/Victoria lineage) virus.

    • Full WHO Recommendation

    Top of Page

    2020-21 WHO Northern Hemisphere recommendations

    3 March 2020

    It is recommended that quadrivalent vaccines for use in the 2020-2021 influenza season (Northern Hemisphere winter) contain the following:

    Egg based vaccines:

  • an A/Guangdong-Maonan/SWL1536/2019 (H1N1)pdm09-like virus;
  • an A/Hong Kong/2671/2019 (H3N2)-like virus;
  • a B/Washington/02/2019-like (B/Victoria lineage) virus; and
  • a B/Phuket/3073/2013-like (B/Yamagata lineage) virus.

    • Cell or recombinant based vaccines:

  • an A/Hawaii/70/2019 (H1N1)pdm09-like virus;
  • an A/Hong Kong/45/2019 (H3N2)-like virus;
  • a B/Washington/02/2019-like (B/Victoria lineage) virus; and
  • a B/Phuket/3073/2013-like (B/Yamagata lineage) virus.

    • It is recommended that trivalent vaccines for use in the 2020-2021 influenza season (Northern Hemisphere winter) contain the following:

    Egg based vaccines:

  • an A/Guangdong-Maonan/SWL1536/2019 (H1N1)pdm09-like virus;
  • an A/Hong Kong/2671/2019 (H3N2)-like virus; and
  • a B/Washington/02/2019-like (B/Victoria lineage) virus

    • Cell or recombinant based vaccines:

  • an A/Hawaii/70/2019 (H1N1)pdm09-like virus;
  • an A/Hong Kong/45/2019 (H3N2)-like virus; and
  • a B/Washington/02/2019-like (B/Victoria lineage) virus.

    • Full WHO Recommendation

    Top of Page

    Australian Influenza Vaccine Committee (AIVC) decision on the influenza vaccine virus composition for Australia in 2020

    23 October 2019

    The AIVC met on 9 October 2019 and recommended that the following viruses be used for influenza vaccines in the 2020 Southern Hemisphere influenza season:

    Egg based quadrivalent vaccines:

  • an A/Brisbane/02/2018 (H1N1)pdm09-like virus;
  • an A/South Australia/34/2019 (H3N2)-like virus;
  • a B/Washington/02/2019-like (B/Victoria lineage) virus; and
  • a B/Phuket/3073/2013-like virus (B/Yamagata/16/88 lineage) virus.

    • Egg based trivalent vaccines:

  • an A/Brisbane/02/2018 (H1N1)pdm09-like virus;
  • an A/South Australia/34/2019 (H3N2)-like virus; and
  • a B/Washington/02/2019-like (B/Victoria lineage) virus.

    • See the TGA website for further information

    Top of Page

    2020 WHO Southern Hemisphere recommendations

    1 October 2019

    It is recommended that quadrivalent vaccines for use in the 2020 influenza season (Southern Hemisphere winter) contain the following:

    Egg based vaccines:

  • an A/Brisbane/02/2018 (H1N1)pdm09-like virus;
  • an A/South Australia/34/2019 (H3N2)-like virus;
  • a B/Washington/02/2019-like (B/Victoria lineage) virus; and
  • a B/Phuket/3073/2013-like virus (B/Yamagata/16/88 lineage) virus.

    • It is recommended that trivalent vaccines for use in the 2020 influenza season (Southern Hemisphere winter) contain the following:

    Egg based vaccines:

  • an A/Brisbane/02/2018 (H1N1)pdm09-like virus;
  • an A/South Australia/34/2019 (H3N2)-like virus; and
  • a B/Washington/02/2019-like (B/Victoria lineage) virus.

    • Full WHO Recommendation

    Top of Page